Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 3
1990 4
1991 2
1992 5
1993 4
1994 2
1995 5
1996 3
1997 4
1998 9
1999 12
2000 6
2001 8
2002 6
2003 8
2004 17
2005 12
2006 8
2007 17
2008 9
2009 12
2010 10
2011 10
2012 11
2013 9
2014 8
2015 22
2016 19
2017 14
2018 25
2019 18
2020 21
2021 18
2022 14
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Results by year

Filters applied: . Clear all
Page 1
Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Gomes-Porras M, et al. Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioning and non-functioning gastroenteropancreatic neuroendocrine tumors. They should also be considered an effective and safe ther …
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioni …
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.
Niederle B, Selberherr A, Bartsch DK, Brandi ML, Doherty GM, Falconi M, Goudet P, Halfdanarson TR, Ito T, Jensen RT, Larghi A, Lee L, Öberg K, Pavel M, Perren A, Sadowski SM, Tonelli F, Triponez F, Valk GD, O'Toole D, Scott-Coombes D, Thakker RV, Thompson GB, Treglia G, Wiedenmann B. Niederle B, et al. Neuroendocrinology. 2021;111(7):609-630. doi: 10.1159/000511791. Epub 2020 Sep 24. Neuroendocrinology. 2021. PMID: 32971521 Free article. Review.
The better understanding of the biological behavior of multiple endocrine neoplasia type 1 (MEN1) organ manifestations and the increase in clinical experience warrant a revision of previously published guidelines. ...
The better understanding of the biological behavior of multiple endocrine neoplasia type 1 (MEN1) organ manifestations and the increa …
Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management.
Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G. Esposito D, et al. Pituitary. 2019 Aug;22(4):422-434. doi: 10.1007/s11102-019-00960-0. Pituitary. 2019. PMID: 31011999 Free PMC article. Review.
PURPOSE: Non-functioning pituitary adenomas (NFPAs) are associated with impaired well-being, increased comorbidities, and reduced long-term survival. ...METHODS: We searched Medline and the Cochrane Library for articles published in English with the following items …
PURPOSE: Non-functioning pituitary adenomas (NFPAs) are associated with impaired well-being, increased comorbidities, and redu …
Management of clinically non-functioning pituitary adenoma.
Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S; French Endocrinology Society non-functioning pituitary adenoma work-group. Chanson P, et al. Ann Endocrinol (Paris). 2015 Jul;76(3):239-47. doi: 10.1016/j.ando.2015.04.002. Epub 2015 Jun 10. Ann Endocrinol (Paris). 2015. PMID: 26072284 Free article. Review.
Silent somatotropinomas.
Lamas C, García-Martínez A, Cámara R, Fajardo-Montanana C, Viguera L, Aranda I. Lamas C, et al. Minerva Endocrinol. 2019 Jun;44(2):137-142. doi: 10.23736/S0391-1977.18.02946-2. Epub 2018 Dec 7. Minerva Endocrinol. 2019. PMID: 30531696 Review.
From a clinical stand-point they are considered and managed as non-functioning pituitary tumors, since they usually come to evidence due to mass-effects (headache, visual impairment, hypopituitarism) or as asymptomatic pituitary incidentalomas. ...However, identific …
From a clinical stand-point they are considered and managed as non-functioning pituitary tumors, since they usually come to ev …
Pituitary incidentaloma.
Constantinescu SM, Maiter D. Constantinescu SM, et al. Presse Med. 2021 Dec;50(4):104081. doi: 10.1016/j.lpm.2021.104081. Epub 2021 Oct 21. Presse Med. 2021. PMID: 34687911 Review.
Autopsy studies have shown that about 10% of deceased individuals harbour a PI, most often a non-functioning microadenoma. In contrast, modern patient series showed that among PIs that come to endocrinological attention, a significant proportion are macroadenomas, a …
Autopsy studies have shown that about 10% of deceased individuals harbour a PI, most often a non-functioning microadenoma. In …
Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now.
Tufano RP, Pace-Asciak P, Russell JO, Suárez C, Randolph GW, López F, Shaha AR, Mäkitie A, Rodrigo JP, Kowalski LP, Zafereo M, Angelos P, Ferlito A. Tufano RP, et al. Front Endocrinol (Lausanne). 2021 Jun 24;12:698689. doi: 10.3389/fendo.2021.698689. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248853 Free PMC article. Review.
Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining …
Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodule …
Silent corticotroph adenomas.
Ben-Shlomo A, Cooper O. Ben-Shlomo A, et al. Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Pituitary. 2018. PMID: 29344907 Review.
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenocorticotrophic hormone (ACTH) without biochemical and clinical manifestation of hypercortisolism. ...CONCLUSION: This article reviews …
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for …
Clinically non-functioning pituitary adenomas.
Chanson P, Wolf P. Chanson P, et al. Presse Med. 2021 Dec;50(4):104086. doi: 10.1016/j.lpm.2021.104086. Epub 2021 Oct 28. Presse Med. 2021. PMID: 34718111 Review.
Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that are not hormonally active. ...
Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that are not hormonally active. ...
Refractory nonfunctioning pituitary adenomas.
Kolitz T, Greenman Y. Kolitz T, et al. Pituitary. 2023 Jun;26(3):278-280. doi: 10.1007/s11102-023-01298-4. Epub 2023 Feb 14. Pituitary. 2023. PMID: 36786972 Review.
Non-functioning pituitary adenomas (NFPAs) comprise silent tumors of different pituitary lineages that tend to escape early detection and present as invasive macroadenomas with symptoms of mass effect. ...
Non-functioning pituitary adenomas (NFPAs) comprise silent tumors of different pituitary lineages that tend to escape early de …
349 results